Screener
G&A at other companies
Other financials
Where this comes from
Reported directly by Teladoc Health in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Teladoc Health’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:54 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001477449-26-000038
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Advertising and marketing | 143,397 | 167,547 | 294,924 | 335,732 |
| Sales | 49,391 | 49,951 | 100,667 | 98,644 |
| Technology and development | 62,861 | 68,784 | 130,726 | 138,742 |
| General and administrative | 104,029 | 108,114 | 206,122 | 220,888 |
| Goodwill impairment | — | — | — | 59,138 |
| Acquisition, integration, and transformation costs | 1,690 | 2,658 | 2,754 | 4,846 |
| Restructuring costs | 904 | 5,692 | 12,879 | 10,039 |
| Amortization of intangible assets | 88,442 | 88,664 | 178,268 | 172,968 |
ITEM 1. Financial Statements
FAQ
- What is Teladoc Health's G&A?
- Teladoc Health (TDOC) reported G&A of $104.03M in Q2 2026.
- How has Teladoc Health's G&A changed year-over-year?
- Teladoc Health's G&A decreased by 3.8% year-over-year, from $108.11M to $104.03M.
- What is the long-term trend for Teladoc Health's G&A?
- Over 4 years (2021 to 2025), Teladoc Health's G&A has grown at a -0.4% compound annual growth rate (CAGR), from $438.01M to $431.89M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about Teladoc Health's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude